NHS patients to benefit from first full access deal in Europe for new CAR-T therapy recommended by NICE

NICE has agreed a managed access agreement, via the Cancer Drugs Fund with manufacturer Kite, so more data can be collected while patients can access the treatment.

Read news story

Blogs

NICE Talks podcasts

NICE Talks brings you the real-life experiences of people working within the NHS, public health and social care.

You will hear the stories behind our work to improve care across the country through evidence-based guidance.

Press and media

Contact the press office: 0300 323 0142 | pressoffice@nice.org.uk